Copyright Reports & Markets. All rights reserved.

Global Prophylactic Human Vaccines Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Prophylactic Human Vaccines Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Type I
      • 1.4.3 Type II
    • 1.5 Market by Application
      • 1.5.1 Global Prophylactic Human Vaccines Market Share by Application (2014-2025)
      • 1.5.2 Pediatric Prophylactic Vaccines
      • 1.5.3 Adult Prophylactic Vaccines
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Prophylactic Human Vaccines Market Size
    • 2.2 Prophylactic Human Vaccines Growth Trends by Regions
      • 2.2.1 Prophylactic Human Vaccines Market Size by Regions (2014-2025)
      • 2.2.2 Prophylactic Human Vaccines Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Prophylactic Human Vaccines Market Size by Manufacturers
      • 3.1.1 Global Prophylactic Human Vaccines Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Prophylactic Human Vaccines Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Prophylactic Human Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.2 Prophylactic Human Vaccines Key Players Head office and Area Served
    • 3.3 Key Players Prophylactic Human Vaccines Product/Solution/Service
    • 3.4 Date of Enter into Prophylactic Human Vaccines Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Prophylactic Human Vaccines Market Size by Type (2014-2019)
    • 4.2 Global Prophylactic Human Vaccines Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Prophylactic Human Vaccines Market Size (2014-2019)
    • 5.2 Prophylactic Human Vaccines Key Players in United States
    • 5.3 United States Prophylactic Human Vaccines Market Size by Type
    • 5.4 United States Prophylactic Human Vaccines Market Size by Application

    6 Europe

    • 6.1 Europe Prophylactic Human Vaccines Market Size (2014-2019)
    • 6.2 Prophylactic Human Vaccines Key Players in Europe
    • 6.3 Europe Prophylactic Human Vaccines Market Size by Type
    • 6.4 Europe Prophylactic Human Vaccines Market Size by Application

    7 China

    • 7.1 China Prophylactic Human Vaccines Market Size (2014-2019)
    • 7.2 Prophylactic Human Vaccines Key Players in China
    • 7.3 China Prophylactic Human Vaccines Market Size by Type
    • 7.4 China Prophylactic Human Vaccines Market Size by Application

    8 Japan

    • 8.1 Japan Prophylactic Human Vaccines Market Size (2014-2019)
    • 8.2 Prophylactic Human Vaccines Key Players in Japan
    • 8.3 Japan Prophylactic Human Vaccines Market Size by Type
    • 8.4 Japan Prophylactic Human Vaccines Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Prophylactic Human Vaccines Market Size (2014-2019)
    • 9.2 Prophylactic Human Vaccines Key Players in Southeast Asia
    • 9.3 Southeast Asia Prophylactic Human Vaccines Market Size by Type
    • 9.4 Southeast Asia Prophylactic Human Vaccines Market Size by Application

    10 India

    • 10.1 India Prophylactic Human Vaccines Market Size (2014-2019)
    • 10.2 Prophylactic Human Vaccines Key Players in India
    • 10.3 India Prophylactic Human Vaccines Market Size by Type
    • 10.4 India Prophylactic Human Vaccines Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Prophylactic Human Vaccines Market Size (2014-2019)
    • 11.2 Prophylactic Human Vaccines Key Players in Central & South America
    • 11.3 Central & South America Prophylactic Human Vaccines Market Size by Type
    • 11.4 Central & South America Prophylactic Human Vaccines Market Size by Application

    12 International Players Profiles

    • 12.1 ALK
      • 12.1.1 ALK Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Prophylactic Human Vaccines Introduction
      • 12.1.4 ALK Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.1.5 ALK Recent Development
    • 12.2 Altimmune
      • 12.2.1 Altimmune Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Prophylactic Human Vaccines Introduction
      • 12.2.4 Altimmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.2.5 Altimmune Recent Development
    • 12.3 Bavarian Nordic
      • 12.3.1 Bavarian Nordic Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Prophylactic Human Vaccines Introduction
      • 12.3.4 Bavarian Nordic Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.3.5 Bavarian Nordic Recent Development
    • 12.4 BiondVax Pharmaceuticals
      • 12.4.1 BiondVax Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Prophylactic Human Vaccines Introduction
      • 12.4.4 BiondVax Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.4.5 BiondVax Pharmaceuticals Recent Development
    • 12.5 Bharat Biotech International
      • 12.5.1 Bharat Biotech International Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Prophylactic Human Vaccines Introduction
      • 12.5.4 Bharat Biotech International Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.5.5 Bharat Biotech International Recent Development
    • 12.6 GlaxoSmithKline
      • 12.6.1 GlaxoSmithKline Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Prophylactic Human Vaccines Introduction
      • 12.6.4 GlaxoSmithKline Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.6.5 GlaxoSmithKline Recent Development
    • 12.7 Hualan Biological Engineering
      • 12.7.1 Hualan Biological Engineering Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Prophylactic Human Vaccines Introduction
      • 12.7.4 Hualan Biological Engineering Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.7.5 Hualan Biological Engineering Recent Development
    • 12.8 Janssen Pharmaceuticals
      • 12.8.1 Janssen Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Prophylactic Human Vaccines Introduction
      • 12.8.4 Janssen Pharmaceuticals Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.8.5 Janssen Pharmaceuticals Recent Development
    • 12.9 MedImmune
      • 12.9.1 MedImmune Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Prophylactic Human Vaccines Introduction
      • 12.9.4 MedImmune Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.9.5 MedImmune Recent Development
    • 12.10 Merck
      • 12.10.1 Merck Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Prophylactic Human Vaccines Introduction
      • 12.10.4 Merck Revenue in Prophylactic Human Vaccines Business (2014-2019)
      • 12.10.5 Merck Recent Development
    • 12.11 Pfizer
    • 12.12 Sanofi Pasteur
    • 12.13 Serum Institute of India
    • 12.14 Shanghai BravoBio
    • 12.15 Seqirus
    • 12.16 SK Chemicals
    • 12.17 Takeda Pharmaceutical Company
    • 12.18 Zydus Cadila

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      In 2018, the global Prophylactic Human Vaccines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Prophylactic Human Vaccines development in United States, Europe and China.

      The key players covered in this study
      ALK
      Altimmune
      Bavarian Nordic
      BiondVax Pharmaceuticals
      Bharat Biotech International
      GlaxoSmithKline
      Hualan Biological Engineering
      Janssen Pharmaceuticals
      MedImmune
      Merck
      Pfizer
      Sanofi Pasteur
      Serum Institute of India
      Shanghai BravoBio
      Seqirus
      SK Chemicals
      Takeda Pharmaceutical Company
      Zydus Cadila

      Market segment by Type, the product can be split into
      Type I
      Type II

      Market segment by Application, split into
      Pediatric Prophylactic Vaccines
      Adult Prophylactic Vaccines

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Prophylactic Human Vaccines status, future forecast, growth opportunity, key market and key players.
      To present the Prophylactic Human Vaccines development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Prophylactic Human Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now